518 related articles for article (PubMed ID: 30398218)
1. Visceral fat and insulin resistance - what we know?
Janochova K; Haluzik M; Buzga M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):19-27. PubMed ID: 30398218
[TBL] [Abstract][Full Text] [Related]
2. The Roles of Adipokines, Proinflammatory Cytokines, and Adipose Tissue Macrophages in Obesity-Associated Insulin Resistance in Modest Obesity and Early Metabolic Dysfunction.
Kang YE; Kim JM; Joung KH; Lee JH; You BR; Choi MJ; Ryu MJ; Ko YB; Lee MA; Lee J; Ku BJ; Shong M; Lee KH; Kim HJ
PLoS One; 2016; 11(4):e0154003. PubMed ID: 27101398
[TBL] [Abstract][Full Text] [Related]
3. [Obesity, inflammation and insulin resistance: which role for adipokines].
Antuna-Puente B; Feve B; Fellahi S; Bastard JP
Therapie; 2007; 62(4):285-92. PubMed ID: 17983554
[TBL] [Abstract][Full Text] [Related]
4. Adipokines: the missing link between insulin resistance and obesity.
Antuna-Puente B; Feve B; Fellahi S; Bastard JP
Diabetes Metab; 2008 Feb; 34(1):2-11. PubMed ID: 18093861
[TBL] [Abstract][Full Text] [Related]
5. [Role of white adipose tissue in vascular complications due to obesity].
Gómez-Hernández A; Perdomo L; Escribano Ó; Benito M
Clin Investig Arterioscler; 2013; 25(1):27-35. PubMed ID: 23522279
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between obesity, inflammation and insulin resistance: new concepts].
Fève B; Bastard JP; Vidal H
C R Biol; 2006 Aug; 329(8):587-97; discussion 653-5. PubMed ID: 16860277
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk of adipokines: a review.
Dutheil F; Gordon BA; Naughton G; Crendal E; Courteix D; Chaplais E; Thivel D; Lac G; Benson AC
J Int Med Res; 2018 Jun; 46(6):2082-2095. PubMed ID: 28974138
[TBL] [Abstract][Full Text] [Related]
8. Adipose tissue inflammation and ectopic lipid accumulation.
Suganami T; Tanaka M; Ogawa Y
Endocr J; 2012; 59(10):849-57. PubMed ID: 22878669
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory characteristics of distinct abdominal adipose tissue depots relate differently to metabolic risk factors for cardiovascular disease: distinct fat depots and vascular risk factors.
Kranendonk ME; van Herwaarden JA; Stupkova T; de Jager W; Vink A; Moll FL; Kalkhoven E; Visseren FL
Atherosclerosis; 2015 Apr; 239(2):419-27. PubMed ID: 25682042
[TBL] [Abstract][Full Text] [Related]
10. Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance.
Kojta I; Chacińska M; Błachnio-Zabielska A
Nutrients; 2020 May; 12(5):. PubMed ID: 32375231
[TBL] [Abstract][Full Text] [Related]
11. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
Kravchun P; Kadykova O; Gabisoniia T
Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
[TBL] [Abstract][Full Text] [Related]
12. Adipose tissue inflammation and metabolic dysfunction: a clinical perspective.
Tam CS; Redman LM
Horm Mol Biol Clin Investig; 2013 Sep; 15(1):19-24. PubMed ID: 25436729
[TBL] [Abstract][Full Text] [Related]
13. Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity.
Goran MI; Alderete TL
Nestle Nutr Inst Workshop Ser; 2012; 73():49-60; discussion p61-6. PubMed ID: 23128765
[TBL] [Abstract][Full Text] [Related]
14. Adipocytokines and the metabolic complications of obesity.
Rasouli N; Kern PA
J Clin Endocrinol Metab; 2008 Nov; 93(11 Suppl 1):S64-73. PubMed ID: 18987272
[TBL] [Abstract][Full Text] [Related]
15. Adipose tissue, inflammation, and cardiovascular disease.
Berg AH; Scherer PE
Circ Res; 2005 May; 96(9):939-49. PubMed ID: 15890981
[TBL] [Abstract][Full Text] [Related]
16. Adipokines at the crossroad between obesity and cardiovascular disease.
Molica F; Morel S; Kwak BR; Rohner-Jeanrenaud F; Steffens S
Thromb Haemost; 2015 Mar; 113(3):553-66. PubMed ID: 25338625
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular diseases and metabolic abnormalities associated with obesity: What is the role of inflammatory responses? A systematic review.
Hamjane N; Benyahya F; Nourouti NG; Mechita MB; Barakat A
Microvasc Res; 2020 Sep; 131():104023. PubMed ID: 32485192
[TBL] [Abstract][Full Text] [Related]
18. The role of adiposity as a determinant of an inflammatory milieu.
Calabrò P; Limongelli G; Pacileo G; Di Salvo G; Golino P; Calabrò R
J Cardiovasc Med (Hagerstown); 2008 May; 9(5):450-60. PubMed ID: 18403996
[TBL] [Abstract][Full Text] [Related]
19. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
Black PH
Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
